Interestingly, NR2E1 was recently found to be upregulated in ERα-negative breast cancer and to play a role in breast cancer cell growth and invasion and was suggested as a possible candidate for therapeutic targeting (29). This evidence concerns the gene NR2E1 and breast carcinoma.